SURVIVAL OF PATIENTS WITH MELANOMA METASTATIC BRAIN METASTASES IN THE ERA OF NOVEL SYSTEMIC THERAPIES IN CARDIFF, WALES

被引：0
|
作者：
Pasquale, Joseph [2 ]
Ocen, Joanita [1 ]
Powell, James [1 ]
Kumar, Satish [1 ]
机构：
[1] Velindre Canc Ctr, Cardiff, S Glam, Wales
[2] Univ Wales Hosp, Cardiff, S Glam, Wales
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz167.055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
    Ugurel, Selma
    Roehmel, Joachim
    Ascierto, Paolo A.
    Flaherty, Keith T.
    Grob, Jean Jacques
    Hauschild, Axel
    Larkin, James
    Long, Georgina V.
    Lorigan, Paul
    McArthur, Grant A.
    Ribas, Antoni
    Robert, Caroline
    Schadendorf, Dirk
    Garbe, Claus
    EUROPEAN JOURNAL OF CANCER, 2017, 83 : 247 - 257
  • [32] Asymptomatic Brain Metastases in Patients With Metastatic Malignant Melanoma
    Zukauskaite, R.
    Schmidt, H.
    Bastholt, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S656 - S656
  • [33] Multimodality management of brain metastases in metastatic melanoma patients
    Samlowski, Wolfram E.
    Jensen, Randy L.
    Shrieve, Dennis C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1699 - 1705
  • [34] Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS
    Papadatos-Pastos, Dionysis
    Januszewski, Adam
    Dalgleish, Angus
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 559 - 567
  • [35] Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
    Elham Vosoughi
    Jee Min Lee
    James R. Miller
    Mehdi Nosrati
    David R. Minor
    Roy Abendroth
    John W. Lee
    Brian T. Andrews
    Lewis Z. Leng
    Max Wu
    Stanley P. Leong
    Mohammed Kashani-Sabet
    Kevin B. Kim
    BMC Cancer, 18
  • [36] Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
    Vosoughi, Elham
    Lee, Jee Min
    Miller, James R.
    Nosrati, Mehdi
    Minor, David R.
    Abendroth, Roy
    Lee, John W.
    Andrews, Brian T.
    Leng, Lewis Z.
    Wu, Max
    Leong, Stanley P.
    Kashani-Sabet, Mohammed
    Kim, Kevin B.
    BMC CANCER, 2018, 18
  • [37] High dose systemic interleukin-2 for metastatic melanoma in patients with treated brain metastases
    Lochhead, R
    McKhann, G
    Hankinson, T
    Isaacson, S
    Hesdorffer, C
    DeRaffele, G
    Sisti, J
    Bruce, J
    Kaufman, H
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S15 - S15
  • [38] Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review
    Spagnolo, Francesco
    Picasso, Virginia
    Lambertini, Matteo
    Ottaviano, Vincenzo
    Dozin, Beatrice
    Queirolo, Paola
    CANCER TREATMENT REVIEWS, 2016, 45 : 38 - 45
  • [39] Surgery, radiation, and systemic therapies in patients with metastatic melanoma.
    Wang, Song
    Zhao, Zhongyun
    Barber, Beth
    Wagner, Volker Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] RADIOSURGERY FOR MELANOMA BRAIN METASTASES IN THE IPILIMUMAB ERA: LONGER SURVIVAL IS POSSIBLE
    Knisely, Jonathan P.
    Kluger, Harriet
    Flanigan, Jaclyn
    Sznol, Mario
    Yu, James B.
    Chiang, Veronica L.
    NEURO-ONCOLOGY, 2011, 13 : 40 - 40
12345